Clinical trial · Observational
Intraoperative Fluorescence of Ganglogliomas and Neuroepithelial Dysembryoplastic Tumors
Intraoperative Fluorescence of Gangliogliomas and Neuroepithelial Dysembryoplastic Tumors
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
One of the key issues of tumour brain surgeries is to clearly define the borders of the tumor. The investigators proposed to evaluate the feasibility of intraoperative fluorescein guidance. Patients will be identified from the list of patients operated on under fluorescence to collect clinical datas. Surgical videos will be analyzed to assess the presence of intraoperative fluorescence and its subjectively judged intensity. MRI data will be extracted from the radiological reports to assess quality extraction. No additional data will be produced
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Surgical Procedure, Unspecified | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Number of Intraoperative tumor fluorescence
- timeFrame
- 2 months
- description
- Number of patients which present intraoperative tumor fluorescence. Fluorescence will be assessed using surgical videos.
Secondary outcomes (3)
- measure
- Number of allergic events
- timeFrame
- 2 months
- description
- Number of allergic events during fluorescein-based surgery
- measure
- Percentage of excised tumour volume
- timeFrame
- 2 months
- description
- Percentage of excised tumour volume. Quality of excision on the post-operative MRI control according to the volume of the remaining pathological contrast intake (complete, subtotal or partial)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Over 18 years old patient * Fluoroguided removal of a histologically proven Ganglioglioma or Dysembryoplastic Neuroepithelial Tumors between 2015-2018 * Surgical video available Exclusion Criteria: * Absence of surgical video * Adults who are subject to legal protection (protection of justice, guardianship, guardianship) * Patient objecting to the use of their data
References
Publications (0)
Data not yet available